Raffaele Galiero

3.9k total citations · 5 hit papers
58 papers, 2.3k citations indexed

About

Raffaele Galiero is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Raffaele Galiero has authored 58 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Cardiology and Cardiovascular Medicine and 16 papers in Epidemiology. Recurrent topics in Raffaele Galiero's work include Diabetes Treatment and Management (15 papers), Liver Disease Diagnosis and Treatment (13 papers) and Cardiovascular Function and Risk Factors (11 papers). Raffaele Galiero is often cited by papers focused on Diabetes Treatment and Management (15 papers), Liver Disease Diagnosis and Treatment (13 papers) and Cardiovascular Function and Risk Factors (11 papers). Raffaele Galiero collaborates with scholars based in Italy, United States and United Kingdom. Raffaele Galiero's co-authors include Ferdinando Carlo Sasso, Luca Rinaldi, Alfredo Caturano, Teresa Salvatore, Raffaele Marfella, Erica Vetrano, Pia Clara Pafundi, Celestino Sardu, Gaetana Albanese and Anna Di Martino and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

Raffaele Galiero

55 papers receiving 2.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications

2023 270 citations Alfredo Caturano, Andrea Mormone et al. profile →
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives

2023 161 citations Riccardo Nevola, Raffaele Galiero et al. International Journal of Molecular Sciences profile →
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors

2022 152 citations Teresa Salvatore, Raffaele Galiero et al. International Journal of Molecular Sciences profile →
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options

2023 89 citations Raffaele Galiero, Alfredo Caturano et al. International Journal of Molecular Sciences profile →
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications

2025 40 citations Alfredo Caturano, Maria Rocco et al. Antioxidants profile →

Peers

Countries citing papers authored by Raffaele Galiero

Since Specialization

Citations

This map shows the geographic impact of Raffaele Galiero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffaele Galiero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffaele Galiero more than expected).

Fields of papers citing papers by Raffaele Galiero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffaele Galiero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffaele Galiero. The network helps show where Raffaele Galiero may publish in the future.

Co-authorship network of co-authors of Raffaele Galiero

This figure shows the co-authorship network connecting the top 25 collaborators of Raffaele Galiero. A scholar is included among the top collaborators of Raffaele Galiero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffaele Galiero. Raffaele Galiero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging Paradigm 2025 ·Reviews in Cardiovascular Medicine ·Alfredo Caturano, (unknown), Giovanni Di Lorenzo, Maria Rocco, (unknown), (unknown), (unknown), (unknown), S. Moretto, Carlo Acierno, Celestino Sardu, Vincenzo Russo, Marco Alfonso Perrone, Erica Vetrano, Raffaele Galiero, Raffaele Marfella, Leonilde Bonfrate, Luca Rinaldi, Caterina Conte, Ferdinando Carlo Sasso	0
2	Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications breakdown → 2025 ·Antioxidants ·Alfredo Caturano, Maria Rocco, (unknown), (unknown), (unknown), Giovanni Di Lorenzo, (unknown), (unknown), Raffaele Galiero, Carlo Acierno, Celestino Sardu, Vincenzo Russo, Erica Vetrano, Caterina Conte, Raffaele Marfella, Luca Rinaldi, Ferdinando Carlo Sasso	40
3	Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 2025 ·Pharmaceuticals ·Erica Vetrano, Raffaele Galiero, Vittorio Simeon, Giuseppe Palmiero, Arturo Cesaro, Alfredo Caturano, Luca Rinaldi, Teresa Salvatore, Roberto Ruggiero, (unknown), Celestino Sardu, Raffaele Marfella, Paolo Calabrò, Ferdinando Carlo Sasso	0
4	Advances in Nanomedicine for Precision Insulin Delivery 2024 ·Pharmaceuticals ·Alfredo Caturano, (unknown), (unknown), Vincenzo Russo, (unknown), Raffaele Galiero, Luca Rinaldi, Marcellino Monda, Celestino Sardu, Raffaele Marfella, Ferdinando Carlo Sasso	16
5	Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 2024 ·International Journal of Molecular Sciences ·Alfredo Caturano, Raffaele Galiero, Erica Vetrano, Celestino Sardu, Luca Rinaldi, Vincenzo Russo, Marcellino Monda, Raffaele Marfella, Ferdinando Carlo Sasso	19
6	The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 2024 ·Biomolecules ·Alfredo Caturano, Raffaele Galiero, Maria Rocco, (unknown), (unknown), (unknown), Giovanni Di Lorenzo, Celestino Sardu, Vincenzo Russo, Erica Vetrano, Marcellino Monda, Raffaele Marfella, Luca Rinaldi, Ferdinando Carlo Sasso	6
7	Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 2024 ·International Journal of Molecular Sciences ·Alfredo Caturano, Erica Vetrano, Raffaele Galiero, Celestino Sardu, Luca Rinaldi, Vincenzo Russo, Marcellino Monda, Raffaele Marfella, Ferdinando Carlo Sasso	7
8	Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 2024 ·SHILAP Revista de lepidopterología ·Alfredo Caturano, (unknown), (unknown), Gaetano Vaudo, Vincenzo Russo, Raffaele Galiero, Luca Rinaldi, Raffaele Marfella, Marcellino Monda, Giovanni Luca, Ferdinando Carlo Sasso	4
9	Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study 2024 ·Diabetes Obesity and Metabolism ·Ernesto Maddaloni, Anda Mihaela Naciu, Carmen Mignogna, Raffaele Galiero, (unknown), Marta Fogolari, (unknown), (unknown), (unknown), Maria Gisella Cavallo, Efisio Cossu, Ferdinando Carlo Sasso, Raffaella Buzzetti, Paolo Pozzilli, (unknown)	3
10	Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 2024 ·Biomedicines ·Alfredo Caturano, Raffaele Galiero, Maria Rocco, (unknown), (unknown), (unknown), Giovanni Di Lorenzo, Celestino Sardu, Erica Vetrano, Marcellino Monda, Raffaele Marfella, Luca Rinaldi, Ferdinando Carlo Sasso	8
11	Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 2023 ·Biomedicines ·Alfredo Caturano, Raffaele Galiero, Giuseppe Loffredo, Erica Vetrano, (unknown), Carlo Acierno, Luca Rinaldi, Aldo Marrone, Teresa Salvatore, Marcellino Monda, Celestino Sardu, Raffaele Marfella, Ferdinando Carlo Sasso	30
12	Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice 2023 ·International Journal of Molecular Sciences ·Arturo Cesaro, (unknown), Erica Vetrano, Giovanni Signore, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Felice Gragnano, Elisabetta Moscarella, Raffaele Galiero, Alfredo Caturano, Roberto Ruggiero, Ferdinando Carlo Sasso, Paolo Calabrò	8
13	Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 2023 ·Biomedicines ·Alfredo Caturano, Gaetana Albanese, Anna Di Martino, Carmine Coppola, Vincenzo Russo, Raffaele Galiero, Luca Rinaldi, Marcellino Monda, Raffaele Marfella, Ferdinando Carlo Sasso, Teresa Salvatore	3
14	Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 2023 ·Biomedicines ·Erica Vetrano, Luca Rinaldi, Andrea Mormone, (unknown), Raffaele Galiero, Alfredo Caturano, Riccardo Nevola, Raffaele Marfella, Ferdinando Carlo Sasso	58
15	Polypharmacy and Major Adverse Events in Atrial Fibrillation 2022 ·Journal of Cardiovascular Pharmacology ·Alfredo Caturano, (unknown), (unknown), Raffaele Galiero, Ferdinando Carlo Sasso	3
16	Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 2022 ·International Journal of Molecular Sciences ·Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, Luca Rinaldi, (unknown), Anna Di Martino, Gaetana Albanese, Erica Vetrano, (unknown), Celestino Sardu, Giovanni Docimo, Raffaele Marfella, Ferdinando Carlo Sasso	26
17	Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 2021 ·International Journal of Molecular Sciences ·Giuseppe Palmiero, Arturo Cesaro, Erica Vetrano, Pia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, Elisabetta Moscarella, Felice Gragnano, Teresa Salvatore, Luca Rinaldi, Paolo Calabrò, Ferdinando Carlo Sasso	71
18	Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects 2021 ·Diagnostics ·Pia Clara Pafundi, Carlo Garofalo, Raffaele Galiero, Silvio Borrelli, Alfredo Caturano, Luca Rinaldi, Michele Provenzano, Teresa Salvatore, Luca De Nicola, Roberto Minutolo, Ferdinando Carlo Sasso	23
19	Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 2021 ·Nutrition Metabolism and Cardiovascular Diseases ·Ferdinando Carlo Sasso, Pia Clara Pafundi, Alfredo Caturano, Raffaele Galiero, Erica Vetrano, Riccardo Nevola, Salvatore Petta, Anna Ludovica Fracanzani, Carmine Coppola, V. Di Marco, (unknown), Rosa Lombardi, Mauro Giordano, Antonio Craxı̀, Alessandro Perrella, Celestino Sardu, Raffaele Marfella, Teresa Salvatore, Luigi Elio Adinolfi, Luca Rinaldi	44
20	Aspirin in a diabetic retinopathy setting: Insights from NO BLIND study 2020 ·Nutrition Metabolism and Cardiovascular Diseases ·Pia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, Carlo Acierno, Chiara de Sio, Erica Vetrano, Riccardo Nevola, Aldo Gelso, Valeria Bono, Ciro Costagliola, Raffaele Marfella, Celestino Sardu, Luca Rinaldi, Teresa Salvatore, Luigi Elio Adinolfi, Ferdinando Carlo Sasso	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact